A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/165 (2006.01) A61K 31/13 (2006.01) A61K 31/137 (2006.01) A61K 31/41 (2006.01) A61K 31/44 (2006.01) A61K 31/4402 (2006.01) A61K 31/495 (2006.01) A61K 31/4965 (2006.01)
Patent
CA 2329328
The invention relates to the use of pharmaceutical compounds having NMDA antagonist activity for treating certain conditions in the gastrointestinal tract, such as functional gastrointestinal disorders, and in particular irritable bowel syndrome (IBS). The invention also relates to pharmaceutical compositions to be used in the treatment of IBS and product comprising such compounds and a pharmaceutical acceptable carrier.
L'invention concerne l'utilisation de composés pharmaceutiques ayant une activité antagoniste de N-méthyle-D-aspartate (NMDA) pour traiter certains états du tractus gastro-instestinal, tels que des troubles fonctionnels gastro-intestinaux, et en particulier le syndrome du côlon irritable. L'invention concerne également des compositions pharmaceutiques à utiliser dans le traitement du syndrome du côlon irritable et un produit contenant de tels composés et un excipient pharmaceutiquement acceptable.
Asghar Aziz
Cabero Jose Luis
Dray Andrew
King Anne
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Use of nmda antagonists for treatment of irritable bowel... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of nmda antagonists for treatment of irritable bowel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nmda antagonists for treatment of irritable bowel... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1646804